20 Nov Next Generation Therapeutics for the Treatment of Myelofibrosis
Multiple non-JAK inhibitor-based therapies are being explored in pre-clinical and clinical settings for the treatment of myelofibrosis, targeting outside of the JAK-STAT pathway. (Ref: Tremblay D et al. Cells. 2021)
#oncologyresearch
https://www.linkedin.com/feed/update/urn:li:activity:6867852221321658368